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22 European countries were interviewed on average 15 months after hospitalisation.
Whether patients exercised or intended to exercise regularly was assessed using the
Stages of Change questionnaire in 8,330 patients. Symptoms of anxiety and
depression were evaluated using the Hospital Anxiety and Depression Scale. Total
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Results: Overall, 50.3% of patients were not intending to exercise regularly, 15.9%
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36.7%, 95% CI 29.8‒44.2). Among patients not exercising regularly, patients with
severe symptoms of depression were less likely to have an intention to exercise
regularly (odds ratio 0.62, 95% CI 0.46‒0.85). Symptoms of anxiety did not affect
regular exercise intention. In sensitivity analysis, results were consistent when
adjusting for total physical activity.
Conclusions: Lower frequency of regular exercise and decreased likelihood of exercise
intention were observed in CHD patients with severe depressive symptoms. Severe
symptoms of depression may preclude CHD patients from performing regular exercise.
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Abstract 
Background: Regular exercise lowers the risk of cardiovascular death in coronary heart disease 
(CHD) patients. We aimed to investigate regular exercise behaviour and intention in relation to 
symptoms of anxiety and depression in CHD patients across Europe. 
Design: Multicentre cross-sectional survey 
Methods: In the EUROASPIRE III survey, 8,966 CHD patients <80 years of age from 22 
European countries were interviewed on average 15 months after hospitalisation. Whether 
patients exercised or intended to exercise regularly was assessed using the Stages of Change 
questionnaire in 8,330 patients. Symptoms of anxiety and depression were evaluated using the 
Hospital Anxiety and Depression Scale. Total physical activity was measured by the 
International Physical Activity Questionnaire in patients from a subset of 14 countries. 
Results: Overall, 50.3% of patients were not intending to exercise regularly, 15.9% were 
intending to exercise regularly, and 33.8% were exercising regularly. Patients with severe 
symptoms of depression less frequently exercised regularly than patients with symptoms in the 
normal range (20.2%, 95% confidence interval (CI) 14.8‒26.8 vs. 36.7%, 95% CI 29.8‒44.2). 
Among patients not exercising regularly, patients with severe symptoms of depression were 
less likely to have an intention to exercise regularly (odds ratio 0.62, 95% CI 0.46‒0.85). 
Symptoms of anxiety did not affect regular exercise intention. In sensitivity analysis, results 
were consistent when adjusting for total physical activity. 
Conclusions: Lower frequency of regular exercise and decreased likelihood of exercise 
intention were observed in CHD patients with severe depressive symptoms. Severe symptoms 
of depression may preclude CHD patients from performing regular exercise. 
 
Abstract word count: 250 
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Introduction 
Physical inactivity is a leading cause of the global disease burden and, along with 
smoking, one of the most important modifiable risk factors.1 Convincing epidemiological 
evidence supports the conclusion that regular exercise decreases the risk of cardiovascular 
disease.2 The benefit of regular exercise in the secondary prevention of coronary heart disease 
(CHD) is well documented: aerobic exercise training reduces the medium to long term risk of 
cardiovascular death by 25% when compared to usual care.3 Indeed, exercise and drug 
interventions may be equally effective in the prevention of mortality outcomes among CHD 
patients.4 The long-term benefit of regular exercise among CHD patients increases with the 
number of weekly sessions.5 Higher exercise levels elicit greater cardio-protective effects and 
more strongly reduce the cardiovascular risk of CHD patients.6 Low risk of cardiovascular 
events during high- and moderate intensity exercise training supports its adoption for secondary 
prevention.7 Accordingly, patients with a previous acute coronary event or procedure should 
undergo regular exercise of moderate-to-vigorous intensity.8 
Elevated symptoms of anxiety and depression worsen the clinical course and prognosis 
of cardiovascular disease, but may not represent independent cardiovascular risk factors.9, 10 
Psychobiological mediators possibly linking anxiety and depression with cardiovascular 
outcomes in CHD patients are unfavourable lifestyle factors: in particular, lack of regular 
exercise has been shown to largely explain the adverse association between depressive 
symptoms and cardiovascular events.11 Moreover, regular exercise and symptoms of anxiety 
and depression seem to be interrelated: notably, depression and anxiety symptoms have been 
prospectively associated with reduced levels of physical exercise.12, 13 However, we are not 
aware of any prior multicentre study that systematically evaluated to what extent symptoms of 
anxiety and depression impact regular exercise among CHD patients. The aim of the present 
study, therefore, was to investigate regular exercise behaviour and intention in relation to 
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symptoms of anxiety and depression in CHD patients across Europe. For this purpose, we took 
the opportunity to analyse data from the EUROASPIRE III survey (EUROpean Action on 
Secondary and Primary Prevention through Intervention to Reduce Events) conducted in 
patients previously hospitalised for coronary events and procedures. 
Methods 
Study participants 
The EUROASPIRE III survey among CHD patients is a cross-sectional study conducted 
in 2006–2007 in 76 study centres in 22 European countries. Patients hospitalised for coronary 
artery bypass graft (CABG), percutaneous coronary intervention (PCI), acute myocardial 
infarction (AMI) and myocardial ischemia were retrospectively identified from hospital 
records.14 Trained research staff reviewed 13,935 medical records and interviewed 8,966 
patients <80 years of age at least 6 months after hospitalisation for their index event or 
procedure. Information on study centres and organisations is provided in the Supplementary 
data as Material S1. The study was approved by local ethics committees. Study participants 
provided written informed consent.  
Regular exercise behaviour and intention 
Whether patients exercised or intended to exercise regularly was assessed using the 
Stages of Change (SoC) short form questionnaire. Figure 1 shows the questionnaire including 
definition of regular exercise, question and answer choices, and the scoring scheme. Study 
centres in all 22 countries that participated in EUROASPIRE III contributed SoC data for 
analysis. We categorized patients not intending to exercise regularly (precontemplation stage), 
patients intending to exercise regularly in the next 30 days or 6 months (contemplation and 
preparation stage, respectively) and patients exercising regularly for less or more than 6 months 
(action and maintenance stage, respectively).15, 16, 17 
 Symptoms of anxiety and depression 
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Symptoms of anxiety and depression during the last 7 days were evaluated using the 
Hospital Anxiety and Depression Scale (HADS). The HADS is a 4-point Likert scale (range 0–
3) with 7 items being related to anxiety and 7 items to depression. Item scores are added to 
obtain the summary scores on anxiety (HADS-A) and depression (HADS-D) separately, 
ranging between 0 and 21. A score <8 is considered to be in the normal range, scores from 8 to 
10 (moderate symptoms) indicate a possible disorder and a score ≥11 (severe symptoms) 
indicates a probable disorder.17  
Covariates 
Covariates were socio-demographic and clinical characteristics (age at interview, sex, 
educational level, current smoking, diabetes, obesity) and factors possibly influencing physical 
performance (diagnostic group, history of stroke, recurrent CHD, cardiac rehabilitation, 
longstanding illness, disability or infirmity, time since hospitalisation). Ten-year age groups 
were used in the analysis. Educational levels considered were primary, secondary, intermediate 
and higher education. Smoking was self-reported and validated by carbon monoxide in breath 
(Bedfont Scientific, Model Micro 4 Smokerlyser, Kent, UK) using ≤10 ppm as cut-off value. 
Diagnosis of diabetes was reported by the patient. Body height and weight were measured using 
calibrated instruments. Obesity was defined as a body mass index ≥30 kg/m2. Information on 
cardiac rehabilitation was assessed by asking: ‘Were you advised to follow a cardiac 
prevention/rehabilitation programme within 3 months of discharge following the index event 
or procedure?’ and ‘If yes, did you attend the cardiac rehabilitation programme offered?’ 
Diagnostic groups were patients’ index events or procedures. History of stroke was self-
reported stroke prior and/or following hospital admission for the index event or procedure. 
Recurrent CHD was self-reported hospitalisation for PCI, CABG, AMI or myocardial ischemia 
since the index event. Longstanding illness, disability or infirmity was assessed by asking: ‘Do 
you have any long-standing illness, disability or infirmity? By long- standing it is meant 
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anything that has troubled you over a period of time, or that is likely to affect you over a period 
of time?’ Total physical activity in the last 7 days was assessed using the International Physical 
Activity Questionnaire (IPAQ) short form in patients from 14 countries.18 
Statistical analysis 
Mean percentages of SoC by HADS-A and HADS-D and odds ratios (ORs) of intending 
to exercise regularly with 95% confidence intervals (CIs) were estimated using logistic 
regression analysis. Models allowed for random variation in regression intercepts between 
countries. To estimate the effects of HADS-A and HADS-D on regular exercise intention, a 
minimal sufficient adjustment set that comprised the above-mentioned covariates was 
determined using directed acyclic graphs (Supplementary data, Figure S1). In sensitivity 
analysis, multivariable associations of HADS-A and HADS-D with exercise intension were 
examined in patients from the subset of 14 countries with IPAQ data. All patients without 
missing data on HADS-A and HADS-D were considered in univariate analyses and patients 
without missing data on all covariates entered the multivariable analysis. Statistical tests were 
two-tailed, and an alpha level of 0.05 was chosen to indicate statistical significance. SAS 
software version 9.4 (SAS Institute Inc., Cary, NC) was used. 
Results 
Study population 
Overall, the number of patients with available data on SoC was 8,330 (Figure S2 in the 
Supplementary data shows the study population by data availability). Compared to patients with 
missing/unclassifiable SoC data, patients with available SoC data showed lower HADS-A 
[median (IQR), 5 (3‒8) vs. 6 (4‒10)] and HADS-D [median (IQR), 4 (2‒7) vs. 5 (3‒8)] scores. 
Frequency distributions of SoC 
Overall, 50.3% of patients (in precontemplation stage) were not intending to exercise 
regularly, 15.9% (in contemplation and preparation stage) were intending to exercise regularly, 
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and 33.8% (in action and maintenance stage) were exercising regularly. The mosaic plots in 
Figure 2 show the frequency distribution of SoC by HADS-A and HADS-D score. The 
frequency of exercising regularly decreases and the frequency of not intending to exercise 
regularly increases with increasing HADS-D score (Figure 2B). This distribution pattern is less 
pronounced with increasing HADS-A score (Figure 2A). Compared to patients with symptoms 
of depression in the normal range (HADS-D <8), patients with severe symptoms (HADS-D 
≥11) less frequently exercised regularly (20.2%, 95% CI 14.8‒26.8 vs. 36.7%, 95% CI 29.8‒
44.2). Table S1 in the Supplementary data provides further mean percentages of SoC by HADS-
A and HADS-D as shown in Figure 2. 
Associations of HADS-A and HADS-D with exercise intention 
Among the subgroup of patients not exercising regularly, the Table presents univariate 
and multivariable associations of HADS-A and HADS-D with exercise intention. In the 
univariate analysis, severe symptoms of anxiety (OR 0.76, 95% CI 0.62‒0.93) and moderate 
(OR 0.71, 95% CI 0.58‒0.85) and severe (OR 0.53, 95% CI 0.41‒0.68) symptoms of depression 
were inversely associated with intending to exercise regularly. Table S2 in the Supplementary 
data shows univariate associations of covariates with intending to exercise regularly. 
In the multivariable analysis, only severe depressive symptoms decreased the likelihood 
of intending to exercise regularly (OR 0.62, 95% CI 0.46‒0.85), whereas the univariate 
associations of severe anxiety and moderate depressive symptoms were attenuated (Table). No 
statistically significant interaction was observed between HADS-A and HADS-D. 
Sensitivity analysis 
The sensitivity analysis included patients from the subset of 14 countries with IPAQ 
data (total physical activity, N=4,438). Overall, 23.1%, 37.6%, and 39.4% respectively had a 
low, moderate and high IPAQ level. Patients with severe symptoms of depression more 
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frequently had a low IPAQ level than patients with depressive symptoms in the normal range 
(41.4%, 95% CI 30.2‒53.8 vs. 19.3%, 95% CI 13.2‒27.3, Table S3 in Supplementary data). 
When further adjusting multivariable associations of HADS-A and HADS-D with 
exercise intention for IPAQ categories in patients not exercising regularly (N=2,632), similar 
results were observed as in the main analysis: in patients with severe depressive symptoms, the 
likelihood of intending to exercise regularly was lower as compared to patients with symptoms 
in the normal range (OR 0.60, 95% CI 0.39‒0.91, p=0.017). 
Discussion 
In the present study, we report on the frequency of regular exercise behaviour and 
intention and on associations of exercise intention with regard to symptoms of anxiety and 
depression among patients with CHD across Europe. Only one fifth of patients with severe 
symptoms of depression exercised regularly, compared to almost two fifths of patients with 
symptoms in the normal range. Severe depressive symptoms had a detrimental effect on planned 
regular exercise, lowering the likelihood of intending to exercise regularly by 40%. Symptoms 
of anxiety did not independently affect intention to exercise regularly. 
Previous studies 
To the best of our knowledge, this is the first multicentre study investigating the 
association of anxiety and depression with regular exercise in CHD patients. Our results support 
the findings of a previous study that prospectively investigated depressive symptoms and 
regular exercise in 502 patients hospitalized for coronary syndromes in the United Kingdom: 
HADS-D score prior to hospital discharge was inversely associated with taking regular exercise 
12 months later.12 Our results further concur with findings of a prospective analysis in the 
Whitehall II study, where symptoms of anxiety and/or depression at baseline decreased the 
probability of exercising regularly as assessed twice during an 8-year follow-up period.13 Of 
note, this study also showed that regular exercise at baseline reduced the likelihood of 
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depressive symptoms at follow-up examinations, suggesting that the association between 
depressive symptoms and regular exercise is bi-directional. Indeed, other studies in general 
population samples similarly observed adverse prospective associations between regular 
exercise and incident depressive symptoms.196, 20 Accordingly, we refrained from examining 
cross-sectional associations of symptoms of anxiety and depression with current regular 
exercise, and analysed associations of HADS with intention to exercise regularly, excluding 
patients who already exercised. Our data show a marked difference in regular exercise between 
patients with severe symptoms of depression and patients with symptoms in the normal range 
as well as a considerable effect of severe depressive symptoms on intention to exercise 
regularly. This suggests that depressive symptoms represent a major barrier to exercise 
behaviour change in CHD patients. Investigating the directionally opposite association than the 
one investigated in the present study, our group previously reported higher HADS-A and 
HADS-D scores in overweight/obese patients intending to exercise regularly when compared 
to patients not intending to become physically active.2117 Thus, in line with general population 
studies, previous results from EUROASPIRE together with the findings of the present study 
provide further evidence for a bi-directional association between depressive symptoms and 
regular exercise. 
Stages of change 
Among patients with stable CHD, aerobic exercise training is recommended ≥3 times a 
week and 30 minutes per session by current European guidelines on cardiovascular disease 
prevention.8 This recommendation is largely consistent with the assessment of regular exercise 
by the SoC questionnaire (3 to 5 times per week for 20-60 minutes per session). According to 
the transtheoretical model, individuals advance through the “stages of change” (from which the 
name of the SoC questionnaire is derived) until they successfully adapt a new health 
behaviour.2218 A study validating SoC against exercise behaviour demonstrated accurate stage 
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distinction by moderate and strenuous exercise.2319 A meta-analysis of studies investigating 
predictors of exercise behaviour showed a large effect size for the relationship between exercise 
intention and actual exercise uptake.240 A meta-analysis of studies on regular exercise SoC 
showed that stage membership well defines the progress of change, concluding that future 
studies should investigate the moderators and mediators of stage transition.251 In this regard, 
the present study identified severe depressive symptoms as a barrier to advancement from the 
precontemplation stage (not intending) to the contemplation and preparation stage (intending 
to exercise). 
The level of total physical activity (not only exercise, but all types of activities) is a 
possible confounding factor in the association of symptoms of anxiety and depression with 
intention to exercise regularly. As outlined above, it was measured using the IPAQ, which 
covers a wide range of physical activity domains and is recommended for use in large study 
samples.262 In sensitivity analysis, a low IPAQ level was more frequently observed in patients 
with severe depressive symptoms. Importantly, however, the multivariable association of 
severe depressive symptoms with intention to exercise regularly persisted after further 
adjustment for IPAQ level, indicating that the effect is independent from total physical activity. 
Implications and perspectives 
Our results show that a majority of CHD patients are not intending to exercise regularly 
and emphasise the need of novel preventive strategies to enhance motivational readiness and 
finally lifestyle change. Randomized controlled trials on the efficacy of SoC-matched exercise 
interventions have shown positive effects on regular exercise in healthy individuals and CHD 
patients.273, 284 A systematic review of intervention studies to increase the adherence to regular 
exercise in cardiac rehabilitation concluded - due to heterogeneous results - that practice 
recommendations could not be made.295 The authors of that study, however, inferred from their 
findings that “individually tailored approaches may increase the likelihood of success”. Based 
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on a large sample of CHD patients from 22 countries, our study results could be helpful in 
designing future behavioural interventions for exercise promotion that may need to be 
specifically tailored to patients with severe symptoms of depression. As an important take home 
message for cardiologists, general practitioners, specialist nurses and other allied professionals, 
we would like to emphasise the adverse association of depressive symptoms with regular 
exercise in CHD patients. 
Limitations 
As study limitations we note the following. Firstly, regular exercise was assessed 
simultaneously with symptoms of anxiety and depression. Secondly, the thresholds used by the 
instruments for assessing regular exercise and total physical activity ignore the benefit of low-
volume exercise among individuals at risk of cardiovascular disease.28 Thirdly, we lacked 
medical data on functional status and relied on information provided by the patients on long-
standing illness, disability or infirmity. Fourth, our study sample can be looked at as survivors 
of a hypothetical cohort of CHD patients. Back in time, it is likely that these survivors exercised 
and intend to exercise more frequently and exhibited sever symptoms of depression less 
frequently than non-survivors. Thus, our study may overestimate the frequency of regular 
exercise and exercise intention, but underestimate the association of HADS-D with exercise 
intention in that hypothetical cohort. 
Conclusions 
In conclusion, our results indicate that severe symptoms of depression may preclude 
CHD patients from performing regular exercise. Strategies for regular exercise promotion may 
need to specifically target CHD patients with severe depressive symptoms across Europe.  
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Figure legends 
 
Figure 1: Stages of Change short form questionnaire 
 
Figure 2: Mosaic plots showing the frequency distribution of Stages of Change by HADS-A 
(Figure 2A, N=8,000) and HADS-D (Figure 2B, N=8,039) score 
HADS, Hospital Anxiety and Depression Scale (HADS-A [Anxiety] and HADS-D 
[Depression]) 
1=Precontemplation stage (not intending to exercise regularly) 
2=Contemplation and preparation stage (intending to exercise regularly) 
3= Action and maintenance stage (exercising regularly) 
Mean proportions from logistic regression models with country modelled as a random effect. 
 
  
17 
 
Regular exercise is any planned physical activity (e.g. brisk walking, aerobics, jogging, 
bicycling, swimming, rowing, etc.) performed to increase physical fitness. Such activity should
be performed 3 to 5 times per week for 20-60 minutes per session. Exercise does not have to 
be painful to be effective but should be done at a level that increases your breathing rate and
causes you to break a sweat.
• Question and aswer choices
Do you exercise regularly according to that definition?
- Yes, I have been for MORE than 6 months (choice #1)
- Yes, I have been for LESS than 6 months (choice #2)
- No, but I intend to in the next 30 days (choice #3)
- No, but I intend to in the next 6 months (choice #4)
- No, and I do NOT intend to in the next 6 months (choice #5)
- Don’t Know/ Unsure (choice #6)
• Scoring scheme
- answerd with choice #1: stage = Maintenance
- answerd with choice #2: stage = Action
- answerd with choice #3: stage = Preparation
- answerd with choice #4: stage = Contemplation
- answerd with choice #5: stage = Precontemplation
- answerd with choice #6: stage = Unclassifiable
Exercising regularly 
Intending to exercise regularly 
Not intending to exercise regularly 
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 Table: U
nivariate and m
ultivariable associations of H
A
D
S-A
 and H
A
D
S-D
 w
ith intending to exercise regularly in patients not exercising 
regularly  
 
 
U
nivariate associations 
M
ultivariable associations 
 
 
N
 
n 
O
R
 
95%
 C
I 
p-value 
N
 
n 
O
R
 
95%
 C
I 
p-value 
H
A
D
S-A
 
<8 
3,510 
891 
1.00 
R
eference 
‒ 
3,351 
858 
1.00 
R
eference 
‒ 
 
8‒10 
980 
226 
0.90 
0.75‒1.07 
0.228 
936 
216 
1.06 
0.87‒1.29 
0.562 
 
≥11 
789 
163 
0.76 
0.62‒0.93 
0.009 
739 
149 
0.99 
0.77‒1.27 
0.951 
H
A
D
S-D
 
<8 
3,879 
1,016 
1.00 
R
eference 
‒ 
3,683 
974 
1.00 
R
eference 
‒ 
 
8‒10 
889 
180 
0.71 
0.58‒0.85 
0.001 
847 
172 
0.82 
0.67‒1.01 
0.067 
 
≥11 
538 
85 
0.53 
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ity, and tim
e since hospitalisation. 
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